Takemasa Y - Search Results

1

Adult survivors of childhood-onset steroid-dependent and steroid-resistant nephrotic syndrome treated with cyclosporine: a long-term single-center experience.

Takemasa Y, Fujinaga S, Nakagawa M, Sakuraya K, Hirano D. Takemasa Y, et al. Pediatr Nephrol. 2024 Feb;39(2):473-482. doi: 10.1007/s00467-023-06108-4. Epub 2023 Aug 22. Pediatr Nephrol. 2024. PMID: 37608237

2

Predictors of Treatment Response and Long-Term Outcomes in Young Children with Steroid-Dependent Nephrotic Syndrome Treated with High-Dose Mizoribine as First-Line Steroid-Sparing Agent.

Fujinaga S, Endo S, Morishita T, Takemasa Y, Onuki Y, Sakuraya K, Hirano D. Fujinaga S, et al. Among authors: takemasa y. Tohoku J Exp Med. 2022 Jan;256(1):85-91. doi: 10.1620/tjem.256.85. Tohoku J Exp Med. 2022. PMID: 35095030 Free article.

3

Independent Risk Factors and 2-Year Outcomes of Acute Kidney Injury after Surgery for Congenital Heart Disease.

Hirano D, Ito A, Yamada A, Kakegawa D, Miwa S, Umeda C, Chiba K, Takemasa Y, Tokunaga A, Ida H. Hirano D, et al. Among authors: takemasa y. Am J Nephrol. 2017;46(3):204-209. doi: 10.1159/000480358. Epub 2017 Sep 1. Am J Nephrol. 2017. PMID: 28858859

4

Independent risk factors and long-term outcomes for acute kidney injury in pediatric patients undergoing hematopoietic stem cell transplantation: a retrospective cohort study.

Hirano D, Kakegawa D, Miwa S, Umeda C, Takemasa Y, Tokunaga A, Kawakami Y, Ito A. Hirano D, et al. Among authors: takemasa y. BMC Nephrol. 2020 Aug 27;21(1):373. doi: 10.1186/s12882-020-02045-8. BMC Nephrol. 2020. PMID: 32854640 Free PMC article.

5

Impact of acute kidney injury in patients prescribed angiotensin-converting enzyme inhibitors over the first two years of life.

Hirano D, Miwa S, Kakegawa D, Umeda C, Takemasa Y, Tokunaga A, Yuhei K, Ito A. Hirano D, et al. Among authors: takemasa y. Pediatr Nephrol. 2021 Jul;36(7):1907-1914. doi: 10.1007/s00467-021-04920-4. Epub 2021 Jan 19. Pediatr Nephrol. 2021. PMID: 33462699

6

Adult chronic kidney disease in childhood-onset nephrotic syndrome.

Takemasa Y, Fujinaga S. Takemasa Y, et al. Pediatr Int. 2022 Jan;64(1):e14846. doi: 10.1111/ped.14846. Epub 2021 Oct 3. Pediatr Int. 2022. PMID: 34601776 No abstract available.

7

Impact of methylprednisolone pulse therapy on anthropometric outcomes in children with immunoglobulin A nephropathy and Henoch-Schönlein purpura nephritis.

Fujinaga S, Takemasa Y. Fujinaga S, et al. Among authors: takemasa y. Pediatr Int. 2022 Jan;64(1):e15025. doi: 10.1111/ped.15025. Pediatr Int. 2022. PMID: 35278275 No abstract available.

8

Thrombotic thrombocytopenic purpura as initial presentation of systemic lupus erythematosus.

Endo S, Fujinaga S, Takemasa Y, Oonuki Y, Sakuraya K. Endo S, et al. Among authors: takemasa y. Pediatr Int. 2022 Jan;64(1):e15297. doi: 10.1111/ped.15297. Pediatr Int. 2022. PMID: 36163643 No abstract available.

9

Effectiveness and safety of Tolvaptan in infants with congenital heart disease.

Sakaguchi H, Hirano D, Saito A, Takemasa Y, Umeda C, Miwa S, Ito A, Oishi K. Sakaguchi H, et al. Among authors: takemasa y. Pediatr Int. 2023 Jan-Dec;65(1):e15580. doi: 10.1111/ped.15580. Pediatr Int. 2023. PMID: 37428842

10

Reference serum creatinine levels according to sex, age, and height in children with Down syndrome.

Nishino T, Endo S, Miyano H, Takemasa Y, Saito M, Umeda C, Tomii Y, Watanabe Y, Nakagawa M, Kakegawa D, Fujinaga S. Nishino T, et al. Among authors: takemasa y. Eur J Pediatr. 2021 Sep;180(9):2977-2983. doi: 10.1007/s00431-021-04078-z. Epub 2021 Apr 15. Eur J Pediatr. 2021. PMID: 33860353

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters